|Videos|March 17, 2023
The Evolution of ctDNA Assays in Colorectal Cancer
The panel comments on how they see ctDNA assay usage evolving in colorectal cancer management.
Advertisement
Episodes in this series
Advertisement
Related to this article
Hematologic specialists discussed where ciltacabtagene autoleucel fits in the treatment paradigm at first relapse and beyond in multiple myeloma.
Advertisement
Advertisement
Trending on CancerNetwork
1
BCMA/GPRC5D CAR T-Cell Therapy Shows Early Efficacy in R/R Multiple Myeloma
2
Aglatimagene Combo Shows Sustained Immune Remodeling in Prostate Cancer
3
What Does TALAPRO-3 Mean for Frontline Treatment of HRR-Altered mHSPC?
4
SBRT Matches Chemoradiation, Preserves QOL Before Pancreatic Surgery
5